Involvement of active oxygen species in protein and oligonucleotide degradation induced by nitrofurans

Biochemistry and Cell Biology

Volumn 83, Issue 2, 2005, Pages 166-175

  Zolla, Lello ^a   Timperio, Anna Maria ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Active oxygen; DNA degradation; Furazolidone; Nitrofurans; Protein fragmentation

Indexed keywords

DERIVATIVES; DNA; MOLECULAR DYNAMICS; OXYGEN; POLYPEPTIDES; RNA; TISSUE;

FURAZOLIDONE; NITROFURANS; OLIGONUCLEOTIDES; PROTEIN-BOUND RESIDUES;

PROTEINS;

3 AMINO 2 OXAZOLIDONE; 3 AMINO 5 MORPHOLINOMETHYL 2 OXAZOLIDINONE; CELL DNA; FURAZOLIDONE; HYDRAZIDE; ISONIAZID; METAL ION; NITROFURAN DERIVATIVE; OLIGONUCLEOTIDE; OXAZOLIDINONE DERIVATIVE; PROTEIN; REACTIVE OXYGEN METABOLITE; RIBOSOME RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA DEGRADATION; ELECTRON SPIN RESONANCE; ENZYME DEGRADATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MUTAGENICITY; NORMAL HUMAN; OXYGEN CONSUMPTION; PROTEIN BINDING; PROTEIN DEGRADATION; RNA DEGRADATION;

CACO-2 CELLS; CATALASE; CYTOCHROMES C; DNA; ELECTRON SPIN RESONANCE SPECTROSCOPY; HEMOGLOBINS; HUMANS; MITOCHONDRIA; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NITROFURANS; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PROTEINS; REACTIVE OXYGEN SPECIES; RNA, RIBOSOMAL;

ANIMALIA;

EID: 23444462443     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o05-023     Document Type: Article

References (46)

1. Abell, C.W., and Kwan, S.W. 2000. Molecular characterization of monoamine oxidases A and B. Prog. Nucleic Acid Res. Mol. Biol. 65: 129-156.
2. Ali, B.H. 1999. Pharmacological, therapeutic and toxicological properties of furazolidone: some recent research. Vet. Res. Commun. 23: 343-360.
3. Ali, B.H., and Bartlet, A.L. 1982. Inhibition of monoamine oxidase in chickens and ducklings by a microbial metabolite of furazolidone. Q. J. Exp. Physiol. 67: 69-79.
4. Buettner, G.R. 1987. Spin trapping: ESR parameters of spin adducts. Free Radical Biol. Med. 3: 259-303.
5. Calla, D.R. 1983. Mutagenicity of nitrofuran derivatives: review. Environ. Mutagen. 5: 745-765.
6. Choudhary, G., and Hansen, H. 1998. Human health perspective on environmental exposure to hydrazines: a review. Chemosphere, 37: 801-843.
7. Claxton, D.L., Houk, V.S., and Hughers, T.J. 1998. Genotoxicity of industrial wastes and affluents. Mutat. Res. 410: 237-243.
8. Connelly, A., Nugent, A., O'Keeffe, M.O., Mulder, P.P.J., van Rhijn, J.A., Kovacsics, L., Fodor, A. et al. 2003. Isolation of bound residues of nitrofuran drugs from tissue by solid-phase extraction with determination by liquid chromatography with UV and tandem mass spectrometric detection. Anal. Chem. Acta, 483: 91-98.
9. Delatur, T., Gremaud, E., Mottier, P., Richoz, J., Arce Vera, F., and Stadler, R.H. 2003. Preparation of stable isotope-labelled 2-nitrobenzaldehyde derivatives for metabolites of nitrofuran antibiotics and their comprehensive characterization by UV, MS, and NMR techniques. J. Agric. Food Chem. 51: 6371-6379.
10. Di Pierro, D., Tavazzi, B., Lazzarino, G., and Giardina, B. 1992. Malondialdehyde is a biochemical marker of peroxidative damage in the isolated reperfused rat heart. Mol. Cell. Biochem. 116: 193-196.
11. Evans, C.A. 1979. Spin trapping. Aldrichim. Acta, 12: 23-29.
12. Graham, D.Y., and Quresci, W.A. 2000. Antibiotic-resistant H. pyliri infection and its treatment. Curr. Pharmaceut. Design, 6: 1537-1544.
13. Hoener, B., Noach, A., Andrup, M., and Yen, T.S. 1989. Nitrofurantoin produces oxidative stress and loss of glutathione and protein thiols in the isolated perfused rat liver. Pharmacology, 38: 363-373.
14. Hoogenboom, L.A.P., Tomassini, O., Oorsprong, M.B.M., and Kuiper, H.A. 1991a. Use of pig hepatocytes to study the inhibition of monoamine oxidase by furazolidone. Toxicol. In Vitro, 29: 185-191.
15. Hoogenboom, L.A.P., Van Kammen, M., Berghmans, M.C.Y., Koeman, J.H., and Kuiper, H.A. 1991b. The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone: a new analytical method for their detection. Food Chem. Toxicol. 29: 321-328.
16. Hoogenboom, L.A.P., Berghmans, M.C.Y., Palman, T.H., Parker, R., and Shaw, I.C. 1992a. Depletion of protein-bound furazolidone metabolites containing the 3-amino-2-oxazolidinone side-chain from liver, kidney and muscle tissues from pigs. Food Addit. Contam. 9: 623-663.
17. Hoogenboom, L.A.P., Van Kammen, M., Huveneers-Oorsprong, M.B.M., and Kuiper, H.A. 1992b. Study on the role of glutathione in the biotransformation and toxicity of furazolidone using pig hepatocytes. Toxicol. In Vitro, 6: 227-237.
18. Hoogenboom, L.A.P., van Bruchen, G.D., Sonne, K., Enninga, I.C., van Rhijn, J.A., Heskamp, H., Huveneers-Oorsprong, M.B.M. et al. 2002. Absorption of a mutagenic metabolite released from protein-bound residues of furazolidone. Environ. Toxicol. Pharmacol. 11: 273-287.
19. Home, E., Cadogan, A., O'Keeffe, M., and Hoogenboom, L.A. 1996. Analysis of protein-bound metabolites of furazolidone and furaltadone in pig liver by high-performance liquid chromatography and liquid chromatography - mass spectrometry. Analyst, 121: 1463-1468.
20. Hussain, S.M., and Frazier, J.M. 2002. Cellular toxicity of hydrazine in primary rat hepatocytes. Toxicol. Sci. 69: 424-432.
21. Ito, K., Yamamoto, K., and Kawanishi, S. 1992. Manganese-mediated oxidative damage of cellular and isolated DNA by isoniazid and related hydrazines: non-Fenton-type hydroxyl radical formation. Biochemistry, 31: 11606-11613.
22. Janes, S.M., Mu, D., Wemmer, D., Smith, A.J., Kaur, S., Maltby, D., Burlingame, A.L., and Klinman, J.P. 1990. A new redox cofactor in eukaryotic enzymes, 6-hydroxy-dopa at the active site of bovine serum amino oxidase. Science (Wash., DC), 248: 981-987.
23. Kobirska-Szeliga, M., and Czeczoth, H. 1994. Characterization of the genotoxic properties of nitrofurans nitrofurazone and furazolidone: review. Acta Biochim. Pol. 41: 1-5.
24. Kumar, L., Toothill, J.R., and Ho, K.B. 1994. Determination of nitrofuran residues in poultry muscle tissues and eggs by liquid chromatography. J AOAC Int. 77: 591-595.
25. Lax, D., Martinez-Zaguilan, R., and Gillies, R.J. 1994. Furazolidone increases thapsigargin sensitive Ca(2+)-ATPase in chick cardiac myocytes. Am. J. Physiol. 267: 734-741.
26. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Polin phenol reagent. J. Biol. Chem. 193: 265-275.
27. Lu, A.Y.H., Miwa, G.T., and Wislocki, P.G. 1998. Toxicological significance of covalently bound drug residues. Rev. Biochem. Toxicol. 9: 1-27.
28. McCracken, R.J., and Kennedy, D.G. 1997. Determination of the furazolidone metabolite, 3-amino-2-oxazolidinone, in porcine tissues using liquid chromatography - thermospray mass spectrometry and the occurrence of residues in pigs produced in Northern Ireland. J. Chromatogr. 691: 87-94.
29. McCracken, R.J., Spence, D.E., Floyd, S.D., and Kennedy, D.G. 2001. Evaluation of the residues of furazolidone and its metabolite, 3-amino-2-oxazolidinone (AOZ) in eggs. Food Addit. Contam. 18: 954-959.
30. Morinan, A., and Garratt, H.M. 1985. An improved fluorimetric assay for brain monoamine oxidase. J. Pharmacol. Methods, 13: 213-223.
31. Nicholls, A.W., Holmes, E., Lindon, J.C., Shockcor, J.P., Duncan Farrant, R., Haselden, J.N., Damment, S.J.P. et al. 2001. Metabonomic investigations into hydrazine toxicity in the rat. Chem. Res. Toxicol. 14: 975-987.
32. Orrenius, S., Ormstad, K., Thor, H., and Jwell, S.A. 1983. Turnover and functions of glutathione studied with isolated hepatic and renal cells. Fed. Proc. 42: 3177-3188.
33. Perez, N.M., and Benedito, M.A. 1997. Activities of monoamine oxidase (MAO) A and B in discrete regions of rat brain after rapid eye movement (REM) sleep deprivation. Pharmacol. Biochem. Behav. 58: 605-608.
34. Powell, H.J., and Gannett, P.M. 2002. Mechanisms of carcinogenicity of aryl hydrazines, aryl hydrazides, and arenediazonium ions. J. Environ. Pathol. Toxicol. Oncol. 21: 1-31.
35. Rasbridge, M.R., and Scott, G.L. 1973. The haemolytic action of dapsone: changes in the red-cell membrane. Br. J. Haematol. 24: 183-193.
36. Runge-Morris, M.A., Iacob, S., and Novak, R.F. 1988. Characterization of hydrazine-stimulated proteolysis in human erythrocytes. Toxicol. Appl. Pharmacol. 94: 414-426.
37. Rupp, H.S., Munns, R.K., Long, A.R., and Plakas, S.M. 1994. Simultaneous determination of nitrofurazone, nitrofurantoin, and furazolidone in channel catfish (Ictalurus punctatus) muscle tissue by liquid chromatography. J. AOAC Int. 77: 344-350.
38. Sax, N.I. 1990. Chemical review: hydrazine. Dangerous Prop. Ind. Mater. Rep. 10: 21-58.
39. Stern, I.V., Hollifield, R.D., Wilk, S., and Buzard, J.A. 1967. The anti-monoamine oxidase effects of furazolidone. J. Pharmacol. Exp. Ther. 156: 492-499.
40. Suzuki, S., Sakurai, T., Nakahara, A., Manabe, T., and Okuyama, T. 1983. Effect of metal substitution on the chromophore of bovine serum amine oxidase. Biochemistry, 22: 1630-1635.
41. Timperio, A.M., Kuiper, H., and Zolla, L. 2003. Identification of a furazolidone metabolite responsible for the inhibition of amino oxidases. Xenobiotica, 33: 153-167.
42. Trohalaki, S., Zellmer, R.J., Pachter, R., Hussain, S.M., and Frazier, M.J. 2002. Risk assessment of high-energy chemicals by in vitro toxicity screening and quantitative structure-activity relationships. Toxicol. Sci. 68: 498-507.
43. 4C-furazolidone in piglets upon oral administration during 10 days and its interaction with tissue macro-molecules. Food Addit. Contam. 3: 331-346.
44. Vroomen, L.H., Berghmans, M.C., and van der Struijs, T.D. 1986b. Determination of furazolidone in swine plasma, muscle, liver, kidney, fat and urine based on high-performance liquid chromatographic separation after solid-phase extraction on Extrelut 1. J. Chromatogr. 362: 141-145.
45. Vroomen, L.H.M., Berghmans, M.C.J., Groten, J.P., Koeman, J.H., and Bladeren, P.J. 1988. Reversible interaction of a reactive intermediate derived from furazolidone with glutathione and protein. Toxicol. Appl. Pharmacol. 95: 53-60.
46. Zolla, L., and Rinalducci, S. 2002. Involvement of active oxygen species in degradation of light-harvesting proteins under light stresses. Biochemistry, 41: 14391-14402.